Shares of Chemical Financial Corp. (NASDAQ:CHFC) reached a new 52-week high on Monday . The company traded as high as $44.46 and last traded at $44.45, with a volume of 177,989 shares traded. The stock had previously closed at $44.00.

CHFC has been the subject of a number of recent research reports. Zacks Investment Research cut Chemical Financial Corp. from a “hold” rating to a “sell” rating in a research report on Thursday, April 21st. Boenning Scattergood reissued a “neutral” rating on shares of Chemical Financial Corp. in a research note on Tuesday, June 7th. Finally, Keefe, Bruyette & Woods increased their target price on Chemical Financial Corp. from $43.00 to $45.00 and gave the stock an “outperform” rating in a research note on Thursday, July 28th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $42.50.

The firm has a market capitalization of $1.71 billion and a price-to-earnings ratio of 17.37. The stock has a 50-day moving average price of $40.08 and a 200 day moving average price of $37.32.

Chemical Financial Corp. (NASDAQ:CHFC) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $0.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.07. On average, analysts anticipate that Chemical Financial Corp. will post $2.79 earnings per share for the current year.

In related news, Director Richard M. Lievense sold 4,500 shares of the business’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $44.03, for a total value of $198,135.00. Following the completion of the sale, the director now directly owns 60,097 shares of the company’s stock, valued at $2,646,070.91. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

A number of hedge funds have recently made changes to their positions in the stock. First Trust Advisors LP raised its stake in shares of Chemical Financial Corp. by 93.5% in the fourth quarter. First Trust Advisors LP now owns 46,256 shares of the company’s stock valued at $1,585,000 after buying an additional 22,346 shares in the last quarter. Swiss National Bank raised its stake in shares of Chemical Financial Corp. by 21.3% in the fourth quarter. Swiss National Bank now owns 49,233 shares of the company’s stock valued at $1,687,000 after buying an additional 8,633 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Chemical Financial Corp. by 1.2% in the fourth quarter. Rhumbline Advisers now owns 51,779 shares of the company’s stock valued at $1,774,000 after buying an additional 615 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Chemical Financial Corp. by 2,562.3% in the fourth quarter. Victory Capital Management Inc. now owns 98,134 shares of the company’s stock valued at $3,363,000 after buying an additional 94,448 shares in the last quarter. Finally, California Public Employees Retirement System raised its stake in shares of Chemical Financial Corp. by 2.3% in the fourth quarter. California Public Employees Retirement System now owns 120,000 shares of the company’s stock valued at $4,112,000 after buying an additional 2,700 shares in the last quarter.

Chemical Financial Corporation is a financial holding company. The Company operates in the commercial banking segment. The Company, through its subsidiary bank, Chemical Bank, offers banking and fiduciary products and services. Its products and services include business and personal checking accounts, savings and individual retirement accounts, time deposit instruments, electronically accessed banking products, residential and commercial real estate financing, commercial lending, consumer financing, debit cards, access to insurance and investment products, corporate and personal wealth management services, and other banking services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.